Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations - Hagens Berman

  • MRVI Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, CA / ACCESS Newswire / April 15, 2025 / Shares of Maravai LifeSciences Holdings (NASDAQ:MRVI) fell nearly 6% on March 19, 2025, following revelations that the company's financial reporting contained material weaknesses. This decline adds to a 21% plunge on February 25, when Maravai postponed its fourth-quarter and full-year 2024 earnings release.